News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Micro Imaging Technology, Inc. (MMTC) Release: the MIT-1000 Will Showcase at Malaysian Microbiology Symposium


12/6/2012 9:51:09 AM

SAN CLEMENTE, CA--(Marketwire - December 05, 2012) - Micro Imaging Technology, Inc. (OTCQB: MMTC) announced a collaboration with Biotek Sdn. Bhd., to exhibit the MIT-1000 rapid microbial identification system, at the 31st Symposium of the Malaysian Society for Microbiology. The symposium will be held in Kota Kinabalu, Sabah, Malaysia from December 13 through the 15th this year and will address contemporary topics on microbiology from both national and regional perspectives.

The Malaysian Society for Microbiology is one of the oldest Societies in Malaysia. It was established forty years ago and today, remains one of the oldest and largest life science membership organizations with members from over 20 disciplines of microbiological specialization such as infectious diseases and agro-disease control, among other areas. "We were pleased to have Biotek MALAYSIA and Dr. LC Chai from University of Malaya visit our facility last month and thrilled when asked to team up to unveil the MIT-1000 at this year's event," stated Jeff Nunez, President and CEO of Micro Imaging Technology, Inc. "Biotek came on board as our Malaysian and our ASEAN distributor in 2009 and had purchased an MIT-1000 Demo System. The System was recently upgraded to the new MIT-1000 commercial system standard which will be showcased. Biotek has an excellent track record in sales, marketing and distribution of scientific products in microbiology and life science in ASEAN countries. They will do real justice to spreading the word on our breakthrough technology in this forum," Nunez continued.

The MIT-1000 is a stand-alone, optically-based, software driven system that can detect pathogenic bacteria and complete an identification test in less than five (5) minutes for pennies per test. According to MIT's Chief Scientist, David Haavig, PhD, "In the US alone, around 76 million cases of food-borne illnesses, resulting in 325,000 hospitalizations and 5,000 deaths, are estimated to occur each year. The leading cause of these illnesses and deaths are three main strains of bacteria: E. coli, Salmonella, and Listeria. Rapid identification of these disease-causing pathogens in food is critical to the health and safety of all consumers."

About: Biotek Sdn. Bhd.

Biotek actively engages as the ASEAN regional sole distributor for research-based products and has successfully established highly active and expanded distribution partnerships throughout ASEAN countries comprising Malaysia, Singapore, Thailand, Brunei, Indonesia, Philippines, Vietnam, Cambodia, Laos and Myanmar. With this distribution network, Biotek aims to provide consistent marketing, technical and service support to all of its customers and distributors throughout ASEAN. It has an established in-house laboratory in Malaysia for conducting related workshops and industrial training in the research and scientific techniques of microbiology and life sciences. This in-house laboratory also provides biochemical microbial ID service and is the center for hands-on training and meeting for all its ASEAN distribution partners and for current as well as prospective customers. Biotek has joint research projects with some local universities and research institutions in Malaysia and hopes to further strengthen its research programs throughout the ASEAN region.

About: Micro Imaging Technology, Inc.

MIT recently announced that it has received U.S. Patent Office approval of its new trademark Micro Identification Technologies® under which the Company plans to market its innovative Rapid Microbial Identification System, the MIT-1000.

MIT is a California-based public company that is also registered to do business under the name Micro Identification Technologies -- a name that more closely corresponds to the process and results achieved by the MIT-1000. MIT has developed and patented a Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process and can annually save thousands of lives and tens of millions of dollars in health care costs. The MIT-1000 identifies bacteria in minutes, not days, and at a significant per test cost savings when compared to any other conventional method. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. The process requires only clean particle-free water and a sample of the unknown bacteria. Revenues for all rapid testing methods exceed $5 billion annually -- with food safety accounting for over $3.5 billion, which is expected to surpass $4.7 billion by 2015 according to BCC Research. In addition, the recently passed "New" U.S. Food Safety Bill is expected to further accelerate the current annual growth rate of 6.6 percent.

You can find more information about our company and about Micro Identification Technologies™. Please visit our newly enhanced website at www.micro-identification.com.

This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission, reference MMTC: www.sec.gov.


CONTACT:
Jeffrey Nunez
President and CEO
Email: Email Contact
Web Site: www.micro-identification.com
Telephone: (949) 388-4546


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES